These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 33204103)
1. CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway. Cheng R; Wang B; Cai XR; Chen ZS; Du Q; Zhou LY; Ye JM; Chen YL Onco Targets Ther; 2020; 13():11485-11498. PubMed ID: 33204103 [TBL] [Abstract][Full Text] [Related]
2. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer. Fan X; Huang J; Hu B; Zhou J; Chen L J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607 [TBL] [Abstract][Full Text] [Related]
3. Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells. Cheng R; Cai XR; Ke K; Chen YL J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):719-725. PubMed ID: 29058285 [TBL] [Abstract][Full Text] [Related]
4. COE targets EphA2 to inhibit vasculogenic mimicry formation induced by hypoxia in hepatocellular carcinoma. Chen J; Dai SY; Wu S; Wu MK; Yu KK; Liu JC; Chang JY; Liu YQ Front Pharmacol; 2024; 15():1421470. PubMed ID: 39050762 [TBL] [Abstract][Full Text] [Related]
5. RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma. Zhang JG; Zhang DD; Liu Y; Hu JN; Zhang X; Li L; Mu W; Zhu GH; Li Q; Liu GL Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1113-1125. PubMed ID: 30779947 [TBL] [Abstract][Full Text] [Related]
6. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma. Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166 [TBL] [Abstract][Full Text] [Related]
7. Curcumin Inhibits Vasculogenic Mimicry Chong Y; Xu S; Liu T; Guo P; Wang X; He D; Zhu G Curr Cancer Drug Targets; 2024; 24(10):1031-1046. PubMed ID: 38299401 [TBL] [Abstract][Full Text] [Related]
8. Doxycycline as an inhibitor of the epithelial-to-mesenchymal transition and vasculogenic mimicry in hepatocellular carcinoma. Meng J; Sun B; Zhao X; Zhang D; Zhao X; Gu Q; Dong X; Zhao N; Liu P; Liu Y Mol Cancer Ther; 2014 Dec; 13(12):3107-22. PubMed ID: 25277383 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma. Wang HF; Wang SS; Zheng M; Dai LL; Wang K; Gao XL; Cao MX; Yu XH; Pang X; Zhang M; Wu JB; Wu JS; Yang X; Tang YJ; Chen Y; Tang YL; Liang XH Cell Prolif; 2019 May; 52(3):e12600. PubMed ID: 30945361 [TBL] [Abstract][Full Text] [Related]
10. Function of BMP4 in the Formation of Vasculogenic Mimicry in Hepatocellular Carcinoma. Li X; Sun B; Zhao X; An J; Zhang Y; Gu Q; Zhao N; Wang Y; Liu F J Cancer; 2020; 11(9):2560-2571. PubMed ID: 32201526 [TBL] [Abstract][Full Text] [Related]
11. ROCK is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell line. Zhang JG; Li XY; Wang YZ; Zhang QD; Gu SY; Wu X; Zhu GH; Li Q; Liu GL PLoS One; 2014; 9(9):e107661. PubMed ID: 25238232 [TBL] [Abstract][Full Text] [Related]
12. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway. Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713 [TBL] [Abstract][Full Text] [Related]
13. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells. Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487 [TBL] [Abstract][Full Text] [Related]
14. Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells. Yeo C; Lee HJ; Lee EO Life Sci; 2019 Mar; 221():267-273. PubMed ID: 30797819 [TBL] [Abstract][Full Text] [Related]
16. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling. Zhang JG; Zhou HM; Zhang X; Mu W; Hu JN; Liu GL; Li Q BMC Cancer; 2020 Jan; 20(1):32. PubMed ID: 31931758 [TBL] [Abstract][Full Text] [Related]
17. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling. Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103 [TBL] [Abstract][Full Text] [Related]
18. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372 [TBL] [Abstract][Full Text] [Related]
20. Galectin-1 Promotes Vasculogenic Mimicry in Gastric Cancer by Upregulating EMT Signaling. You X; Liu Q; Wu J; Wang Y; Dai J; Chen D; Zhou Y; Lian Y J Cancer; 2019; 10(25):6286-6297. PubMed ID: 31772662 [No Abstract] [Full Text] [Related] [Next] [New Search]